DaVita Inc. (NYSE:DVA) Shares Sold by Wedge Capital Management L L P NC

Wedge Capital Management L L P NC cut its position in DaVita Inc. (NYSE:DVA) by 6.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 222,007 shares of the company’s stock after selling 16,487 shares during the quarter. Wedge Capital Management L L P NC owned approximately 0.27% of DaVita worth $33,201,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Transcendent Capital Group LLC acquired a new stake in shares of DaVita in the third quarter valued at approximately $25,000. Blue Trust Inc. raised its position in DaVita by 56.4% in the 3rd quarter. Blue Trust Inc. now owns 330 shares of the company’s stock valued at $54,000 after purchasing an additional 119 shares during the last quarter. Quarry LP acquired a new stake in DaVita during the 3rd quarter worth $60,000. Versant Capital Management Inc grew its position in DaVita by 58.7% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after purchasing an additional 169 shares during the last quarter. Finally, Point72 Hong Kong Ltd acquired a new position in DaVita in the second quarter valued at $68,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Trading Up 0.9 %

Shares of DaVita stock opened at $166.28 on Friday. The firm has a market cap of $13.63 billion, a price-to-earnings ratio of 17.94, a price-to-earnings-growth ratio of 0.75 and a beta of 0.92. DaVita Inc. has a 52-week low of $103.40 and a 52-week high of $169.51. The company’s 50-day simple moving average is $157.11 and its 200-day simple moving average is $152.71. The company has a quick ratio of 1.33, a current ratio of 1.37 and a debt-to-equity ratio of 15.78.

DaVita (NYSE:DVA) last released its earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.76 by ($0.17). The business had revenue of $3.26 billion for the quarter, compared to analyst estimates of $3.25 billion. DaVita had a return on equity of 88.18% and a net margin of 6.53%. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.85 EPS. As a group, equities research analysts anticipate that DaVita Inc. will post 9.71 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on DVA shares. Barclays increased their target price on shares of DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. Truist Financial increased their price objective on DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a research report on Monday, October 7th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $161.80.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.